News

UF, Princeton researchers unveil precision DNA editing breakthrough

University of Florida researchers, in collaboration with Princeton University, have developed a new genome-editing technology called CODE that enables more precise DNA modifications without cutting both strands of DNA. The system could help expand the possibilities of gene-editing therapies for genetic diseases, agriculture and developmental biology.

ChE’s Taofeek Tejuosho inducted into elite honor society

Recent chemical engineering doctoral graduate Taofeek Tejuosho was inducted into the National Edward Alexander Bouchet Graduate Honor Society, recognizing his excellence in scholarship, leadership and service. A member of the Sampath Computational Design of Soft Materials research group, Tejuosho was the only inductee from the Herbert Wertheim College of Engineering this year.

ChE’s Yeongseon Jang honored as outstanding junior faculty member 

The Herbert Wertheim College of Engineering on Thursday awarded Yeongseon Jang, Ph.D., the 2025-2026 Pramod P. Khargonekar Award, which honors outstanding junior faculty members undergoing tenure and promotion review.

ChE advisory board welcomes 2 familiar faces 

Two chemical engineering graduates are returning to the University of Florida, this time to help guide the department that sealed their successes. Alumni Gretta Granado Huerta and Mark Pepple, Ph.D., joined the Department of Chemical Engineering’s advisory board this spring. 

Three beloved ChE professors to retire this year

Three longtime Department of Chemical Engineering professors are retiring this year. They are known for their years of dedication to research, academics and, certainly, student mentorship.

Novel approach to heat-based cancer imaging earns engineering student UF Health award 

Aniela Nozka, a third-year chemical engineering Ph.D. student, earned a UF Health Cancer Institute award for developing a novel approach to heat-based cancer treatment. Her research uses magnetic particle imaging and 3D-printed models to improve patient-specific dosing, aiming to target tumors more precisely while minimizing harm to healthy tissue.